MedTrace Logo

Internet Program for Workers With Subthreshold Depression

NCT02335554 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 300

Last updated 2015-01-12

No results posted yet for this study

Summary

Depression is one of the most prevalent mental disorders to afflict adults. It seriously impacts role functioning and often takes a recurrent or chronic course. Because most adults who suffer from depression never receive treatment, there is a critical need to develop interventions that can be easily implemented and widely disseminated. Interventions that reduce the performance-impairing symptoms of subclinical depression and prevent the onset of major depression can improve employee well-being, while reducing healthcare costs and improving productivity. This project produced a mobile-web program to activate cognitive behavioral skills in workers with subthreshold depression, reduce depression symptoms, improve functioning in the workplace, and potentially reduce the risk for escalation to full-syndrome depression.

Conditions

Interventions

BEHAVIORAL

MoodHacker

Mobile-web app to educate users about depression and promote daily mood and positive activity monitoring.

BEHAVIORAL

Alternative Care

Online information about depression from government and other trusted sources to educate users about depression.

Sponsors & Collaborators

  • Oregon Center for Applied Science, Inc.

    lead INDUSTRY

Principal Investigators

  • Amy J Birney, MPH, MCHES · Oregon Center for Applied Science

Study Design

Allocation
RANDOMIZED
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-08-31
Primary Completion
2013-06-30
Completion
2013-06-30

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02335554 on ClinicalTrials.gov